Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study
<strong>Background<br></strong> The influence of renin–angiotensin–aldosterone system (RAAS) inhibitors on the critically ill COVID-19 patients with pre-existing hypertension remains uncertain. This study examined the impact of previous use of angiotensin-converting enzyme inhibito...
主要な著者: | Sato, K, White, N, Fanning, JP, Obonyo, N, Yamashita, MH, Appadurai, V, Ciullo, A, May, M, Worku, ET, Helms, L, Ohshimo, S, Juzar, DA, Suen, JY, Bassi, GL, Fraser, JF, Arora, RC, Nichol, A |
---|---|
その他の著者: | COVID-19 Critical Care Consortium Investigators |
フォーマット: | Journal article |
言語: | English |
出版事項: |
BioMed Central
2022
|
類似資料
-
Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study
著者:: Kei Sato, 等
出版事項: (2022-03-01) -
New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
著者:: Akira Nishiyama, 等
出版事項: (2010-01-01) -
The renin angiotensin aldosterone system and COVID-19
著者:: Hadeel A. Alsufyani, 等
出版事項: (2020-08-01) -
Beyond the circulating renin angiotensin aldosterone system
著者:: Walmor eDe Mello
出版事項: (2014-07-01) -
THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
著者:: V. I. Podzolkov, 等
出版事項: (2016-01-01)